Esteban Cvitkovic Selected Research

Esteban Cvitkovic Research Topics

Disease

23	Neoplasms (Cancer) 01/2018 - 11/2003
4	Breast Neoplasms (Breast Cancer) 01/2017 - 03/2006
4	Colonic Neoplasms (Colon Cancer) 05/2009 - 04/2006
3	Carcinoma (Carcinomatosis) 01/2015 - 11/2003
2	Glioblastoma (Glioblastoma Multiforme) 11/2016 - 10/2013
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 09/2016 - 04/2015
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 09/2011 - 11/2006
2	Ovarian Neoplasms (Ovarian Cancer) 11/2009 - 04/2006
2	Neoplasm Metastasis (Metastasis) 10/2006 - 03/2006
1	Leukemia 12/2019
1	Triple Negative Breast Neoplasms 01/2017
1	Mesothelioma 01/2017
1	Malignant Mesothelioma 01/2017
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 12/2016
1	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 11/2016
1	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 11/2016
1	Lymphoma (Lymphomas) 09/2016
1	Neuroblastoma 01/2016
1	B-Cell Lymphoma (Lymphoma, B Cell) 04/2015
1	Thyroid Neoplasms (Thyroid Cancer) 10/2007
1	Nasopharyngeal Carcinoma 10/2007
1	Prostatic Neoplasms (Prostate Cancer) 10/2007
1	Neutropenia 10/2006
1	Peripheral Nervous System Diseases (PNS Diseases) 10/2006
1	Febrile Neutropenia 10/2006
1	Adenocarcinoma 03/2006
1	Thrombocytopenia (Thrombopenia) 05/2004

Drug/Important Bio-Agent (IBA)

10	OTX015IBA 12/2019 - 04/2015
7	Oxaliplatin (Eloxatin)FDA LinkGeneric 09/2011 - 03/2006
6	Cisplatin (Platino)FDA LinkGeneric 01/2017 - 11/2003
6	irofulvenIBA 10/2007 - 11/2003
5	Antineoplastic Agents (Antineoplastics)IBA 09/2016 - 04/2008
4	Fluorouracil (Carac)FDA LinkGeneric 09/2011 - 11/2003
3	Proteins (Proteins, Gene)FDA Link 01/2018 - 09/2006
3	PlatinumIBA 09/2011 - 09/2006
2	ChromatinIBA 01/2018 - 01/2016
2	Everolimus FDA Link 01/2017 - 09/2016
2	Gemcitabine FDA Link 01/2017 - 09/2011
2	Monoclonal AntibodiesIBA 09/2016 - 01/2015
2	compound 0118IBA 09/2014 - 10/2013
2	Pharmaceutical PreparationsIBA 11/2009 - 05/2009
2	Protein Kinase CIBA 05/2009 - 04/2008
2	3-ingenyl angelateIBA 05/2009 - 04/2008
2	AnthracyclinesIBA 10/2006 - 03/2006
2	Vinorelbine (Navelbine)FDA LinkGeneric 10/2006 - 03/2006
2	taxaneIBA 10/2006 - 03/2006
1	Estrogens (Estrogen)FDA Link 01/2017
1	Progesterone FDA LinkGeneric 01/2017
1	Pemetrexed (MTA)FDA Link 01/2017
1	Anaplastic Lymphoma KinaseIBA 11/2016
1	Agammaglobulinaemia Tyrosine KinaseIBA 09/2016
1	Histone Deacetylase InhibitorsIBA 09/2016
1	Rituximab (Mabthera)FDA Link 09/2016
1	ibrutinibIBA 09/2016
1	Vorinostat FDA Link 09/2016
1	DNA (Deoxyribonucleic Acid)IBA 01/2016
1	Cytostatic AgentsIBA 04/2015
1	Bromodomain Containing ProteinsIBA 04/2015
1	Peptide Hydrolases (Proteases)FDA Link 01/2015
1	cathepsin SIBA 01/2015
1	saccharide-binding proteinsIBA 09/2014
1	Galectin 1 (LGALS1)IBA 09/2014
1	Sunitinib (Sutent)FDA Link 10/2013
1	Tyrosine Kinase InhibitorsIBA 10/2013
1	cis-diammine(pyridine)chloroplatinum(II)IBA 09/2011
1	Paclitaxel (Taxol)FDA LinkGeneric 09/2011
1	PolymersIBA 11/2009
1	hydroxypropyl methacrylateIBA 11/2009
1	ProLindacIBA 11/2009
1	StaurosporineIBA 05/2009
1	Cytotoxins (Cytolysins)IBA 04/2008
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 04/2008
1	ingenolIBA 04/2008
1	Protein Isoforms (Isoforms)IBA 04/2008
1	Mitogen-Activated Protein KinasesIBA 04/2008
1	Hormones (Hormone)IBA 10/2007
1	Capecitabine (Xeloda)FDA Link 10/2007
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 08/2006
1	lysyl- arginyl- alanyl- lysyl- alanyl- lysyl- threonyl- threonyl- lysyl- lysyl- arginine (PKCS)IBA 08/2006
1	IsoenzymesIBA 08/2006
1	Taxoids (Taxanes)IBA 03/2006

Therapy/Procedure

5	Therapeutics 01/2017 - 08/2006
2	Drug Therapy (Chemotherapy) 11/2016 - 03/2006
1	Treatment Delay 05/2004